current MC is $2.5m only and obviously since the new CEO joining, the fundamentals are improving, costs saving achieved, expanding slow but stable like the JV with shine clinical already exceeded most of its initial targets within few months ,so I won’t be surprised the next QR will be profitable again.
Needless to say its largest shareholder already worked out and took shares @ 2.8c per share, which is 300% of today’s SP, hence my SP target is 3c+.
hold tightly, I wish dividend of 0.3-1.0c /share just a matter of time. JTL has 3000+ clinics customers in UK, any new cooperation, new technology applied, its business will boom very soon.
JTL Price at posting:
0.9¢ Sentiment: Buy Disclosure: Held
